发明名称 |
Treatment of cancers and metastases with suspensions of cilengitide in carrier |
摘要 |
The present invention relates to a pharmaceutical composition of oligopeptides, preferably cyclic oligopeptides, said composition further comprising one or more lipophilic and/or amphiphilic compounds, in the presence or absence of water as the main ingredients, the use of the lipophilic and/or amphiphilic compounds for making pharmaceutical compositions of said oligopeptides, and methods of making said pharmaceutical composition. |
申请公布号 |
AU2012266803(B2) |
申请公布日期 |
2017.02.02 |
申请号 |
AU20120266803 |
申请日期 |
2012.05.16 |
申请人 |
Merck Patent GmbH |
发明人 |
Goodman, Simon;Amendt, Christiane;Eber, Marcus |
分类号 |
A61K9/10;A61K9/00;A61K9/16;A61K38/12;A61K47/44 |
主分类号 |
A61K9/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|